— Know what they know.
Not Investment Advice

ELDN NASDAQ

Eledon Pharmaceuticals, Inc.
1W: -1.5% 1M: -2.5% 3M: +77.6% YTD: +140.1% 1Y: +27.1% 3Y: +76.0% 5Y: -56.0%
$3.89
+0.00 (+0.00%)
 
Weekly Expected Move ±8.6%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 50 · $233.2M mcap · 54M float · 2.71% daily turnover · Short 57% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
25.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -1672.6%  ·  5Y Avg: -265.4%
Cost Advantage ★
33
Intangibles
25
Switching Cost
26
Network Effect
18
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ELDN has No discernible competitive edge (25.4/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -1672.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$5
Avg Target
$7
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$5.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-16 Leerink Partners Thomas Smith Initiated $5 +82.8% $2.73
2025-06-18 H.C. Wainwright Yi Chen Initiated $9 +223.7% $2.78

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
4
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ELDN receives an overall rating of C+. Strongest factors: D/E (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 C C+
2026-05-13 B- C
2026-05-12 C+ B-
2026-04-01 B- C+
2026-03-23 C B-
2026-03-06 C+ C
2026-02-18 C C+
2026-02-09 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
82
Earnings Quality
61
Growth
Value
30
Momentum
Safety
0
Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.89
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
Ohlson O-Score
-4.67
Bankruptcy prob: 0.9%
Low Risk
Credit Rating
BB
Score: 43.7/100
Trend: Stable
Earnings Quality
OCF/NI: 0.88x
Accruals: -4.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ELDN scores -0.89, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ELDN scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ELDN's implied 0.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ELDN receives an estimated rating of BB (score: 43.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-5.60x
PEG
0.00x
P/S
0.00x
P/B
4.35x
P/FCF
-5.03x
P/OCF
EV/EBITDA
-2.52x
EV/Revenue
EV/EBIT
-2.52x
EV/FCF
-3.10x
Earnings Yield
-22.57%
FCF Yield
-19.90%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ELDN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.921
EBT / EBIT
×
EBIT Margin
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.628
Assets / Equity
=
ROE
-61.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ELDN's ROE of -61.3% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.89
Median 1Y
$1.58
5th Pctile
$0.28
95th Pctile
$8.88
Ann. Volatility
99.2%
Analyst Target
$5.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David-Alexandre C. Gros,
M.D. Chief Executive Officer
$613,196 $268,660 $3,216,148
Steven Perrin, Ph.D.
President and Chief Scientific Officer
$484,919 $109,080 $1,696,284
Paul Little Financial
ancial Officer
$479,226 $303,000 $1,592,943

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,216,148
Avg Employee Cost (SGA/emp): $514,667
Employees: 33

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
33
+6.5% YoY
Revenue / Employee
Profit / Employee
$-1,382,333
NI: $-45,617,000
SGA / Employee
$514,667
Avg labor cost proxy
R&D / Employee
$2,008,091
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -27.9% -31.6% -19.5% -20.2% -21.3% -21.7% -70.9% -71.6% -1.2% -1.2% -3.8% -4.1% -3.6% -1.7% -57.7% -30.4% 23.4% -1.3% -35.8% -61.3% -61.31%
ROA -26.8% -30.4% -18.8% -19.5% -20.5% -20.9% -66.8% -67.5% -1.1% -1.1% -1.9% -2.0% -1.8% -85.1% -27.2% -14.3% 11.0% -59.9% -22.0% -37.7% -37.66%
ROIC -25.6% -34.2% -36.4% -37.3% -38.6% -38.7% -1.1% -1.1% -1.2% -1.2% 78.1% 77.6% 85.2% 1.0% 2.6% 2.9% 4.0% 3.2% -16.1% -16.7% -16.73%
ROCE -15.1% -17.4% -22.2% -22.7% -23.5% -23.5% -1.0% -1.0% -1.7% -1.7% -2.0% -2.0% -1.8% -1.9% -72.6% -76.9% -64.8% -62.9% -37.2% -38.7% -38.70%
Gross Margin
Operating Margin
Net Margin
EBITDA Margin
FCF Margin
OCF Margin
ROE 3Y Avg snapshot only -8.81%
ROE 5Y Avg snapshot only -5.54%
ROA 3Y Avg snapshot only -83.83%
ROIC Economic snapshot only -49.71%
Cash ROA snapshot only -29.00%
Cash ROIC snapshot only -16.87%
CROIC snapshot only -16.87%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -4.20 -2.90 -1.89 -1.57 -0.92 -1.03 -0.36 -0.38 -0.23 -0.28 -0.25 -0.33 -0.68 -1.78 -6.81 -13.73 14.28 -2.50 -2.50 -4.43 -5.596
P/S Ratio 0.000
P/B Ratio 0.61 0.48 0.40 0.34 0.21 0.24 0.37 0.40 0.39 0.49 6.05 8.57 15.48 19.16 2.09 2.21 1.77 1.69 0.83 2.53 4.353
P/FCF -5.18 -3.14 -2.26 -1.77 -1.13 -1.40 -1.11 -1.12 -1.02 -1.03 -1.10 -1.61 -2.95 -3.69 -5.21 -4.79 -3.24 -2.97 -1.83 -5.03 -5.026
P/OCF
EV/EBITDA -0.11 0.67 0.51 0.74 1.27 1.16 0.28 0.25 0.16 0.10 0.04 -0.06 -0.40 -0.54 -0.89 -1.06 -0.73 -0.65 0.27 -2.52 -2.519
EV/Revenue
EV/EBIT -0.11 0.67 0.51 0.73 1.26 1.15 0.28 0.25 0.16 0.10 0.04 -0.06 -0.40 -0.54 -0.89 -0.96 -0.65 -0.58 0.23 -2.52 -2.517
EV/FCF -0.14 0.77 0.65 0.87 1.61 1.59 0.85 0.73 0.71 0.37 0.18 -0.29 -1.61 -2.34 -2.27 -2.24 -1.08 -0.90 0.30 -3.10 -3.100
Earnings Yield -23.8% -34.5% -52.8% -63.5% -1.1% -97.5% -2.8% -2.6% -4.4% -3.5% -4.0% -3.0% -1.5% -56.0% -14.7% -7.3% 7.0% -39.9% -40.1% -22.6% -22.57%
FCF Yield -19.3% -31.8% -44.3% -56.5% -88.1% -71.5% -90.5% -89.6% -97.9% -97.1% -90.7% -62.1% -34.0% -27.1% -19.2% -20.9% -30.9% -33.6% -54.7% -19.9% -19.90%
PEG Ratio snapshot only 0.002
Price/Tangible Book snapshot only 3.317
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 46.57 46.57 20.07 20.07 20.07 20.07 9.19 9.19 9.19 9.19 14.41 14.41 14.41 14.41 12.42 12.42 12.42 12.42 7.40 7.40 7.397
Quick Ratio 46.57 46.57 20.07 20.07 20.07 20.07 9.19 9.19 9.19 9.19 14.41 14.41 14.41 14.41 12.42 12.42 12.42 12.42 7.40 7.40 7.397
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.005
Net Debt/Equity -0.60 -0.60 -0.51 -0.51 -0.51 -0.51 -0.66 -0.66 -0.66 -0.66 -7.04 -7.04 -7.04 -7.04 -1.18 -1.18 -1.18 -1.18 -0.97 -0.97 -0.970
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.003
Debt/EBITDA -0.00 -0.00 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.008
Net Debt/EBITDA 3.90 3.39 2.29 2.24 2.17 2.18 0.64 0.63 0.38 0.39 0.30 0.29 0.34 0.31 1.16 1.20 1.45 1.50 1.89 1.57 1.565
Interest Coverage -6.09 -7.00 -7545.40 -7800.40 -7793.40 -17593.20 -509.69 -509.98 -448.28 -479.65
Equity Multiplier 1.03 1.03 1.04 1.04 1.04 1.04 1.10 1.10 1.10 1.10 12.36 12.36 12.36 12.36 1.50 1.50 1.50 1.50 1.74 1.74 1.737
Cash Ratio snapshot only 7.269
Cash to Debt snapshot only 208.012
FCF to Debt snapshot only -107.477
Defensive Interval snapshot only 565.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover 0.41 0.41
Receivables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover 0.21 0.21 0.12 0.15 0.18 0.21 0.19 0.19 0.19 0.19 0.24 0.24 0.24 0.23 0.11 0.08 0.05 0.03 0.00 0.00
DSO
DIO 888 898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DPO 1709 1728 2975 2397 1987 1701 1963 1969 1969 1963 1545 1533 1521 1584 3457 4701 7431 14102
Cash Conversion Cycle
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue
Net Income -56.9% -50.1% -51.3% -55.1% -35.1% -21.5% -1.5% -1.5% -2.9% -2.8% -95.8% -1.1% -13.0% 46.6% 79.0% 89.7% 1.1% -3.1% -26.1% -3.1% -3.10%
EPS 90.0% 88.7% 92.6% -60.5% -40.3% -26.1% -1.7% -1.5% -1.3% -79.6% -11.4% 0.8% 35.8% 71.1% 91.5% 96.0% 1.0% 25.9% 0.1% -1.8% -1.81%
FCF -1.2% -2.7% -90.1% -75.5% -35.7% 3.4% 1.7% 5.4% -5.0% -41.6% -39.1% -27.0% -17.7% 6.2% -19.6% -42.4% -70.3% -79.7% -31.9% -26.2% -26.20%
EBITDA -65.7% -61.1% -59.2% -57.1% -32.4% -14.9% -1.4% -1.4% -2.7% -2.7% -96.2% -94.3% -4.2% -12.0% 30.1% 32.7% 36.6% 42.6% 41.6% 26.8% 26.81%
Op. Income -1.3% -2.3% -1.8% -99.5% -57.5% -18.1% -7.9% -8.8% -7.9% -9.1% -8.1% -4.2% -11.4% -31.7% -64.1% -81.7% -87.4% -53.8% -18.0% -11.3% -11.32%
OCF Growth snapshot only -26.20%
Asset Growth snapshot only 33.93%
Equity Growth snapshot only 15.78%
Debt Growth snapshot only -32.81%
Shares Change snapshot only 45.77%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 1.1% 1.1% 1.2% 1.2% 1.2% 1.2% 1.0% 1.0% 1.0% 1.0% -23.3% -23.3% -23.3% -23.3% 1.3% 1.3% 1.3% 1.3% 36.8% 36.8% 36.81%
Assets 5Y 23.7% 23.7% 41.8% 41.8% 41.8% 41.8% 34.7% 34.7% 34.7% 34.7% 39.2% 39.2% 39.2% 39.2% 74.6% 74.6% 74.6% 74.6% 3.8% 3.8% 3.80%
Equity 3Y 1.1% 1.1% 1.2% 1.2% 1.2% 1.2% 1.1% 1.1% 1.1% 1.1% -66.4% -66.4% -66.4% -66.4% -10.4% -10.4% -10.4% -10.4% 17.6% 17.6% 17.56%
Book Value 3Y -29.8% -29.8% -26.3% -25.5% -19.7% -17.0% -22.5% -15.8% -29.6% -30.9% -89.6% -73.5% -76.3% -78.4% -43.7% -48.8% -48.9% -48.9% -33.3% -40.9% -40.90%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earnings Stability 0.21 0.05 0.00 0.13 0.48 0.80 0.65 0.67 0.60 0.62 0.76 0.74 0.79 0.55 0.29 0.19 0.07 0.39 0.04 0.07 0.075
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.86 0.91 0.50 0.50 0.50 0.50 0.50 0.50 0.95 0.81 0.50 0.50 0.20 0.99 0.90 0.50 0.500
Earnings Smoothness
ROE Trend 1.38 1.51 0.70 0.86 0.78 0.96 -0.88 -0.89 -1.54 -1.52 -23.27 -25.05 -21.81 -9.76 12.17 13.21 12.38 5.55 11.77 12.35 12.352
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate 23.4%
Internal Growth Rate 12.3%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.81 0.92 0.84 0.89 0.81 0.73 0.32 0.34 0.22 0.28 0.23 0.21 0.23 0.48 1.31 2.87 -4.41 0.84 1.37 0.88 0.882
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.882
CapEx/Revenue
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.05 -0.02 -0.03 -0.02 -0.04 -0.06 -0.45 -0.45 -0.86 -0.80 -1.46 -1.61 -1.39 -0.44 0.08 0.27 0.59 -0.09 0.08 -0.04 -0.045
Sloan Accruals snapshot only -0.072
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -88.9% -9.8% -0.7% -0.8% -1.3% -1.1% 0.0% 0.0% -1.0% -80.4% -75.8% -53.4% -43.1% -38.6% -54.1% -51.0% -40.8% -40.0% -47.1% -15.5% -15.47%
Total Shareholder Return -88.9% -9.8% -0.7% -0.8% -1.3% -1.1% 0.0% 0.0% -1.0% -80.4% -75.8% -53.4% -43.1% -38.6% -54.1% -51.0% -40.8% -40.0% -47.1% -15.5% -15.47%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.95 0.94 0.94 0.95 0.97 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.02 0.97 1.01 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.07 1.08 0.48 0.30 0.15 -0.14 0.76 0.56 0.92 0.921
EBIT Margin
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.04 1.04 1.04 1.04 1.04 1.04 1.06 1.06 1.06 1.06 1.99 1.99 1.99 1.99 2.13 2.13 2.13 2.13 1.63 1.63 1.628
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.89 $-2.13 $-2.33 $-2.50 $-2.65 $-2.69 $-6.39 $-6.22 $-6.06 $-4.83 $-7.11 $-6.17 $-3.89 $-1.40 $-0.61 $-0.25 $0.19 $-1.03 $-0.60 $-0.70 $-0.70
Book Value/Share $12.86 $12.86 $11.07 $11.44 $11.50 $11.50 $6.11 $5.89 $3.51 $2.81 $0.30 $0.24 $0.17 $0.13 $1.98 $1.53 $1.53 $1.53 $1.81 $1.22 $0.89
Tangible Book/Share $7.39 $7.39 $5.60 $5.79 $5.82 $5.82 $3.76 $3.63 $2.16 $1.73 $-1.04 $-0.84 $-0.60 $-0.45 $1.43 $1.11 $1.11 $1.11 $1.38 $0.93 $0.93
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.53 $-1.97 $-1.95 $-2.23 $-2.15 $-1.97 $-2.06 $-2.11 $-1.34 $-1.33 $-1.63 $-1.28 $-0.90 $-0.67 $-0.79 $-0.71 $-0.84 $-0.87 $-0.83 $-0.61 $-0.61
OCF/Share $-1.53 $-1.97 $-1.95 $-2.23 $-2.15 $-1.97 $-2.06 $-2.11 $-1.34 $-1.33 $-1.63 $-1.28 $-0.90 $-0.67 $-0.79 $-0.71 $-0.84 $-0.87 $-0.83 $-0.61 $-0.61
Cash/Share $7.71 $7.71 $5.73 $5.92 $5.95 $5.95 $4.09 $3.95 $2.35 $1.88 $2.11 $1.70 $1.21 $0.92 $2.34 $1.82 $1.82 $1.82 $1.77 $1.19 $0.99
EBITDA/Share $-1.97 $-2.27 $-2.47 $-2.62 $-2.71 $-2.71 $-6.36 $-6.20 $-6.04 $-4.82 $-7.10 $-5.74 $-3.57 $-2.92 $-2.01 $-1.50 $-1.24 $-1.20 $-0.93 $-0.75 $-0.75
Debt/Share $0.01 $0.01 $0.05 $0.05 $0.05 $0.05 $0.05 $0.05 $0.03 $0.02 $0.02 $0.01 $0.01 $0.01 $0.02 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Net Debt/Share $-7.70 $-7.70 $-5.67 $-5.87 $-5.89 $-5.89 $-4.04 $-3.90 $-2.32 $-1.86 $-2.09 $-1.69 $-1.20 $-0.91 $-2.33 $-1.81 $-1.80 $-1.80 $-1.76 $-1.18 $-1.18
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -0.889
Altman Z-Prime snapshot only -1.059
Piotroski F-Score 4 4 1 2 2 2 2 2 1 1 2 2 2 3 2 2 3 3 1 2 2
Beneish M-Score
Ohlson O-Score snapshot only -4.675
ROIC (Greenblatt) snapshot only -71.94%
Net-Net WC snapshot only $0.31
EVA snapshot only $-68718120.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 60.96 61.06 74.12 61.83 48.16 48.62 33.55 44.63 44.29 44.50 33.33 33.43 33.23 33.37 44.45 44.42 44.36 44.33 44.03 43.66 43.664
Credit Grade snapshot only 12
Credit Trend snapshot only -0.752
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms